Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Leflunomide medac 15mg film-coated tablets

Active Ingredient:
leflunomide
Company:  
medac Pharma LLP See contact details
ATC code: 
L04AK01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{external_link}

Leflunomide medac - RMP Patient Leaflet

Risk Management Educational Material
{external_link}

Leflunomide medac - RMP Physician Leaflet

{healthcare_pro_orange} For Healthcare Professionals
In addition to the Summary of Product Characteristics, this leaflet was developed by the marketing authorisation holder to inform you about all delicate issues potentially arising from Leflunomide medac therapy. Counselling patients on important risks associated with Leflunomide medac therapy and appropriate precautions when using the medicine is required.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

medac Pharma LLP
Company image
Address
Scion House, Stirling University Innovation Park, Stirling, FK9 4NF, UK
Telephone
+44 (0)1786 458 086
Medical Information e-mail
[email protected]
WWW
www.medacpharma.co.uk